Arcus Biosciences
RCUS
RCUS
171 hedge funds and large institutions have $997M invested in Arcus Biosciences in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 61 increasing their positions, 59 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
13.38% less ownership
Funds ownership: 71.53% → 58.15% (-13%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
42% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 31
Holders
171
Holding in Top 10
2
Calls
$5.35M
Puts
$3.19M
Top Buyers
| 1 | +$34.9M | |
| 2 | +$21.6M | |
| 3 | +$12.6M | |
| 4 |
LCM
Laurion Capital Management
New York
|
+$10.3M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.74M |
Top Sellers
| 1 | -$35.7M | |
| 2 | -$9.97M | |
| 3 | -$9.85M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$8.19M |
| 5 |
Pictet Asset Management
Carouge,
Switzerland
|
-$6.78M |